Home > Insider Trading > Filing (0001209191-20-010546)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Cl&Ao	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-02-17	2,496	$241.50	35,410	No	4	F	Direct
Common Stock	Disposition	2020-02-18	360	$241.75	35,050	No	4	S	Direct
Common Stock	Disposition	2020-02-18	1,098	$242.64	33,952	No	4	S	Direct
Common Stock	Disposition	2020-02-18	560	$243.59	33,392	No	4	S	Direct
Common Stock	Disposition	2020-02-18	416	$244.64	32,976	No	4	S	Direct
Common Stock	Disposition	2020-02-18	694	$245.52	32,282	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $241.75 (range $241.24 to $242.23).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $242.64 (range $242.24 to $243.21).
Open market sales reported on this line occurred at a weighted average price of $243.59 (range $243.24 to $244.15).
Open market sales reported on this line occurred at a weighted average price of $244.64 (range $244.25 to $245.23).
Open market sales reported on this line occurred at a weighted average price of $245.52 (range $245.26 to $245.86).